Eli Lilly has filed three new separate lawsuits accusing vendors and a medical spa of selling knock-off versions of their ...

Grassi Investment Management lessened its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.2% in the ...

Boyd Watterson Asset Management LLC OH trimmed its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 9.3% during ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Eli Lilly sued three medical spas and online vendors for selling products that claim to contain the ingredient in its ...

MangoRx said it “strongly refutes” claims made by Eli Lilly that it improperly copied blockbuster weight-loss medicines for ...

Eli Lilly has triggered multiple Buy signals, including Timing, SAR, and Fundamental, with a 12-month target of ~$1,150. See ...

MangoRx remains committed to its mission and plans to continue to enhance patient care by offering new and innovative ...

Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, ...

A group of U.S. senators are digging into the direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer this ...

Highlights,Eli Lilly and Company (LLY) is set to announce its fiscal third-quarter earnings on October 30, with analysts ...

Lilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products ...